Why Oral GLP-1 Drugs Could Change Diabetes Care
GLP-1 medications are currently the talk of the town. If you live with type 2 diabetes, you've probably heard a lot about these and…
This study is for adults diagnosed with Type 2 Diabetes and fatty liver disease caused by MASH, sometimes called “fatty liver.” It focuses on people with liver cirrhosis due to MASH and aims to test the safety and effectiveness of a once-weekly injection of an investigational medication as a potential treatment.
To take part in the study, participants should be:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator